NVS (Novartis AG) Change In Inventory : $-42 Mil (TTM As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Change In Inventory?

Novartis AG's change in inventory for the quarter that ended in Mar. 2025 was $55 Mil. It means Novartis AG's inventory declined by $55 Mil from Dec. 2024 to Mar. 2025 .

Novartis AG's change in inventory for the fiscal year that ended in Dec. 2024 was $-225 Mil. It means Novartis AG's inventory increased by $225 Mil from Dec. 2023 to Dec. 2024 .

Novartis AG's Total Inventories for the quarter that ended in Mar. 2025 was $5,829 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Novartis AG's Days Inventory for the quarter that ended in Mar. 2025 was 163.33.

Inventory Turnover measures how fast the company turns over its inventory within a year. Novartis AG's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.56.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novartis AG's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.42.

Novartis AG Change In Inventory Historical Data

The historical data trend for Novartis AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Change In Inventory Chart

Novartis AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-543.00

-102.00

-560.00

-546.00

-225.00

Novartis AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-128.00	-18.00	90.00	-169.00	55.00

Novartis AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42 Mil.

Novartis AG (NYSE:NVS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Novartis AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5776	/	3227	*	365 / 4
	=	163.33

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Novartis AG's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3227	/	5776
	=	0.56

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Novartis AG's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5776	/	13620
	=	0.42

Novartis AG Change In Inventory Related Terms

Thank you for viewing the detailed overview of Novartis AG's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NOVN:Mexico NVS N:Mexico NOVNz:UK 0K9E:UK 0QLR:UK NOT0:Germany NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.